Wichita, Kansas, March 15, 2022 – Fagron, a leading FDA Registered 503B Outsourcing Facility and a national supplier of compound sterile preparations, is expanding their
Fagron is excited to share our continued partnership with Premier and the renewal of our GPO contract. This agreement covers Fagron’s entire high-quality portfolio, ready
Product & Service Providers in: ADMIXTURE COMPOUNDING SERVICES (503B OUTSOURCING FACILITIES) 340B IV/INFUSION ADHERENCE As Seen In: View Fagron Sterile Services’ Ad:
MasterControl at Fagron: Rapid Production of High-Quality Drug Products Fagron Sterile Services US (FSS) is a 503B Outsourcing Provider vertically integrated with Fagron, a leader
5 Easy Steps to Clean Out Your Medicine Cabinet Quarantine and Clean With Spring in full bloom and many engaged in COVID-19 protective health measures
Current Good Manufacturing Practice (cGMP) in 503B Outsourcing Facilities: Essentials of Drug Quality and Patient Safety 503B drug compounding facilities came into being as a
Intravenous Bag Platform Launches, Supports COVID-19 Medication Demand WICHITA, Kansas, March 30, 2021 / PR Newswire / – Fagron Sterile Services US (FSS), a leader
Healthcare facilities need a reliable pharmaceutical compounding manufacturer that incorporates industry-leading product safety standards and cGMP compliant operations. They want a partner with a proven
Not Just Another 503B Outsourcing Facility OR Anesthesia | Ophthalmics | Pain Management | Specialty Presentations Fagron Sterile Services US (FSS) integrates state-of-the-art quality to
Not Just Another 503B Outsourcing Facility OR Anesthesia | Ophthalmics | Pain Management | Specialty Presentations Fagron Sterile Services US (FSS) integrates state-of-the-art quality to
Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.
